Bay Street News, 2019

-Landmark Agreement with Sumitomo Dainippon Pharma to provide major financial backing and safeguards for minority shareholders-Myovant to report top-line data […]

– Presentation with live audio webcast on Wednesday, November 20th at 5:20 PM DST –Norwood, MA , Nov. 12, 2019 […]

BELTSVILLE, Md., Nov. 12, 2019 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]

GENEVA, Nov. 12, 2019 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent […]

MISSISSAUGA, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) — goeasy Ltd. (TSX: GSY) (“goeasy” or the “Company”) is pleased to announce […]

HAMPTON, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the […]

CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a genome editing company […]

– Commenced Phase 2b ReNeu Clinical Trial for Patients with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas (NF1-PN) –– Received Important Regulatory […]

SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops […]

SALT LAKE CITY, Nov. 12, 2019 (GLOBE NEWSWIRE) — As part of its continued global expansion, LifeVantage Corporation (Nasdaq:LFVN) has formally […]